In the APS group, the IPS-1 level showed no significant difference when compared with that in the control group (p > 0.05), and the expression of NF-κB was significantly higher than that in the control group (p < 0.05). This evidence concerns the gene NFKB1 and autoimmune polyendocrinopathy.